CINCINNATI--(BUSINESS WIRE)--Jan. 12, 2004--Meridian Bioscience,
Inc., (Nasdaq:VIVO) today announced that Gregory S. Ballish has joined
Meridian Bioscience, Inc. as Vice President Sales and Marketing.
Ballish joins Meridian as a pharmaceutical and diagnostics industry
veteran, having spent the last five years in senior sales management
and strategic customer marketing roles with Janssen Pharmaceutica
(Johnson & Johnson subsidiary). Mr. Ballish has also held positions of
national sales and marketing responsibility for Ortho Clinical
Diagnostics (J&J) and had been responsible for launching several key
products and leading them to a position of market strength. Earlier in
his career, Mr. Ballish held senior sales and marketing roles with
DuPont and Abbott Laboratories.
Mr. Ballish holds a Master of Business Administration degree from
Arizona State University and a Bachelor of Science in Finance from
As Vice President, Mr. Ballish will provide strategic leadership
to Meridian's sales and marketing organization and will further expand
Meridian's position as a market leader in innovative products that are
designed to enhance patient well-being while reducing total costs of
John A Kraeutler, President and Chief Operating Officer stated, "I
am delighted to welcome Greg to Meridian's senior management team.
Greg has a broad background in developing and leading sales and
marketing teams within the pharmaceutical and diagnostics industries.
His focus on strong relationships and innovative marketing approaches
will provide Meridian with important leadership in clinical
diagnostics and life science."
Meridian is a fully integrated life science company that
manufactures, markets and distributes a broad range of innovative
diagnostic test kits, purified reagents and related products and
offers biopharmaceutical enabling technologies. Utilizing a variety of
methods, these products provide accuracy, simplicity and speed in the
early diagnosis and treatment of common medical conditions, such as
gastrointestinal, viral, urinary and respiratory infections. All
Meridian diagnostic products are used outside of the human body and
require little or no special equipment. The Company's products are
designed to enhance patient well-being while reducing the total
outcome costs of healthcare. Meridian has strong market positions in
the areas of gastrointestinal and upper respiratory infections,
serology, parasitology and fungal disease diagnosis. In addition,
Meridian is a supplier of rare reagents and specialty biologicals
along with proteins and other biologicals used by biopharmaceutical
companies engaged in research for new drugs and vaccines. The Company
markets its products to hospitals, reference laboratories, research
centers, veterinary testing centers, physician offices and diagnostics
manufacturers in more than 60 countries around the world. The
Company's shares are traded through Nasdaq's National Market, symbol
VIVO. Meridian's website address is www.meridianbioscience.com.
CONTACT: Meridian Bioscience, Inc.
John A. Kraeutler, 513-271-3700
SOURCE: Meridian Bioscience, Inc.